Altimmune to report first quarter 2023 financial results and provide business update on may 11, 2023

Gaithersburg, md., may 04, 2023 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2023 financial results on thursday, may 11, 2023 and will provide a business update.
ALT Ratings Summary
ALT Quant Ranking